Clinical Scorecard: Evaluating the Discriminative Efficacy of CVAI Versus Traditional Insulin Resistance Metrics for MAFLD in Chinese Adults with Type 2 Diabetes

At a Glance

Key Highlights

• CVAI demonstrated the highest discriminative ability for MAFLD (AUC = 0.754)
• 1,313 participants (44.6%) were diagnosed with MAFLD
• CVAI significantly improved risk reclassification over traditional IR indices
• The association between CVAI and MAFLD was stronger in females and older adults
• All IR indices were independently associated with MAFLD

Guideline-Based Recommendations

Diagnosis

• Use CVAI as a non-invasive screening tool for MAFLD in T2DM patients

Management

• Consider the role of visceral adiposity in managing MAFLD

Monitoring & Follow-up

• Monitor CVAI alongside traditional IR indices for comprehensive assessment

Risks

• High prevalence of MAFLD in T2DM increases risk of microvascular and macrovascular complications

Patient & Prescribing Data

Chinese adults with type 2 diabetes mellitus

CVAI may serve as an effective screening tool for identifying high-risk individuals

Clinical Best Practices

• Incorporate CVAI into routine assessments for MAFLD in T2DM patients
• Utilize non-invasive indices to reduce the need for liver biopsies

Related Resources & Content

• Source Article